JP2005536568A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005536568A5 JP2005536568A5 JP2005505623A JP2005505623A JP2005536568A5 JP 2005536568 A5 JP2005536568 A5 JP 2005536568A5 JP 2005505623 A JP2005505623 A JP 2005505623A JP 2005505623 A JP2005505623 A JP 2005505623A JP 2005536568 A5 JP2005536568 A5 JP 2005536568A5
- Authority
- JP
- Japan
- Prior art keywords
- topiramate
- release
- core
- dosage form
- structural polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- KJADKKWYZYXHBB-XBWDGYHZSA-N Topiramic acid Chemical compound C1O[C@@]2(COS(N)(=O)=O)OC(C)(C)O[C@H]2[C@@H]2OC(C)(C)O[C@@H]21 KJADKKWYZYXHBB-XBWDGYHZSA-N 0.000 claims 12
- 229960004394 topiramate Drugs 0.000 claims 12
- 239000004094 surface-active agent Substances 0.000 claims 6
- 239000000203 mixture Substances 0.000 claims 5
- 229920000642 polymer Polymers 0.000 claims 5
- 239000006186 oral dosage form Substances 0.000 claims 4
- 230000003381 solubilizing effect Effects 0.000 claims 4
- 239000002552 dosage form Substances 0.000 claims 3
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims 2
- 239000013543 active substance Substances 0.000 claims 2
- 238000013270 controlled release Methods 0.000 claims 2
- 239000012528 membrane Substances 0.000 claims 2
- 230000001225 therapeutic effect Effects 0.000 claims 2
- OIALAIQRYISUEV-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]e Polymers CCCCCCCCCCCCCCCCCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO OIALAIQRYISUEV-UHFFFAOYSA-N 0.000 claims 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims 1
- 229920002701 Polyoxyl 40 Stearate Polymers 0.000 claims 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 claims 1
- 230000001174 ascending effect Effects 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 229920001983 poloxamer Polymers 0.000 claims 1
- 229940099429 polyoxyl 40 stearate Drugs 0.000 claims 1
- 230000002035 prolonged effect Effects 0.000 claims 1
- 229920000428 triblock copolymer Polymers 0.000 claims 1
Claims (10)
- 活性剤を長期間にわたり放出するように適合せしめられた、約50〜60%の活性剤、約5〜15%の構造用重合体担体および約15〜40%の可溶化界面活性剤(solubillizing surfactant)を含んでなる調節放出性治療組成物。
- トピラメート(topiramate)を長期間にわたり放出するように適合せしめられた、トピラメート、構造用重合体担体および可溶化界面活性剤を含んでなる調節放出性治療組成物。
- トピラメートの薬用量が約10mg〜250mgの間である請求項2の組成物。
- 構造用重合体が約100,000〜約200,000の分子量のポリエチレンオキシドである請求項2の組成物。
- 可溶化界面活性剤がステアリン酸ポリオキシル40、ステアリン酸ポリオキシル50、ポロキサマー類、およびエチレンオキシド:プロピレンオキシド:エチレンオキシドのa:b:a三ブロック共重合体よりなる群から選択される請求項2の組成物。
- (a)i.トピラメート、
ii.構造用重合体、
iii.可溶化界面活性剤
を含んでなる芯、
(b)芯を少なくとも部分的に取り囲む半透膜、および
(c)環境に対するトピラメートの放出を可能にするように芯と連結する半透膜に通じる出口オリフィス
を含んでなる1日1回投与用の調節放出性経口投薬形態であって、投薬形態がトピラメートを長期間にわたり放出する形態。 - トピラメートを実質的に0次放出速度で放出するように適合せしめられた請求項6の調節放出性経口投薬形態。
- トピラメートを実質的に上昇する放出速度で放出するように適合せしめられた請求項2の調節放出性経口投薬形態。
- トピラメートが芯の55%であり、構造用重合体が芯の約11.5%であり、そして可溶化界面活性剤が芯の約30%である請求項6の調節放出性経口投薬形態。
- 約50〜60%のトピラメート、約5〜15%の構造用重合体担体および約15〜40%の可溶化界面活性剤を含有するカプセル形状の錠剤芯投薬形態を経口的に投与することを含んでなるトピラメートに応答する症状を処置する方法であって、投薬形態がトピラメートを実質的に上昇する放出速度で長期間にわたり放出する方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39999302P | 2002-07-29 | 2002-07-29 | |
US46851903P | 2003-05-07 | 2003-05-07 | |
PCT/US2003/023438 WO2004010970A1 (en) | 2002-07-29 | 2003-07-28 | Formulations and dosage forms for controlled delivery of topiramate |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2005536568A JP2005536568A (ja) | 2005-12-02 |
JP2005536568A5 true JP2005536568A5 (ja) | 2006-09-14 |
Family
ID=31191336
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2005505623A Withdrawn JP2005536568A (ja) | 2002-07-29 | 2003-07-28 | トピラメートの調節分配用の調剤および投薬形態 |
Country Status (12)
Country | Link |
---|---|
US (1) | US20040115262A1 (ja) |
EP (1) | EP1534238A1 (ja) |
JP (1) | JP2005536568A (ja) |
AR (1) | AR040722A1 (ja) |
AU (1) | AU2003256848A1 (ja) |
CA (1) | CA2494233A1 (ja) |
MX (1) | MXPA05001184A (ja) |
NZ (1) | NZ537543A (ja) |
PE (1) | PE20040131A1 (ja) |
TW (1) | TW200410728A (ja) |
UY (1) | UY27908A1 (ja) |
WO (1) | WO2004010970A1 (ja) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050232995A1 (en) | 2002-07-29 | 2005-10-20 | Yam Nyomi V | Methods and dosage forms for controlled delivery of paliperidone and risperidone |
ES2570454T3 (es) | 2003-03-26 | 2016-05-18 | Egalet Ltd | Sistema de liberación controlada de morfina |
ATE454886T1 (de) * | 2003-03-26 | 2010-01-15 | Egalet As | Matrixzubereitungen für die kontrollierte darreichung von arzneistoffen |
US20040202717A1 (en) | 2003-04-08 | 2004-10-14 | Mehta Atul M. | Abuse-resistant oral dosage forms and method of use thereof |
AU2004268549A1 (en) * | 2003-08-22 | 2005-03-10 | Alza Corporation | Stepwise delivery of topiramate over prolonged period of time |
WO2005020959A2 (en) * | 2003-09-02 | 2005-03-10 | Alza Corporation | Novel drug compositions and dosage forms of topiramate |
KR101169614B1 (ko) * | 2003-09-26 | 2012-08-03 | 알자 코포레이션 | 상승한 방출 속도를 나타내는 제어 방출 제제 |
EP1708684A2 (en) | 2003-09-26 | 2006-10-11 | Alza Corporation | Drug coating providing high drug loading and methods for providing the same |
MXPA06005462A (es) * | 2003-11-14 | 2006-12-15 | Johnson & Johnson | Liberacion controlada de topiramato en formas de dosificacion liquida. |
EP1701708A2 (en) * | 2003-12-29 | 2006-09-20 | Alza Corporation | Novel drug compositions and dosage forms of topiramate |
AU2004312082A1 (en) * | 2003-12-29 | 2005-07-21 | Alza Corporation, Inc. | Novel drug compositions and dosage forms |
EP1701707A2 (en) * | 2003-12-29 | 2006-09-20 | Alza Corporation, Inc. | Drug granule coatings that impart smear resistance during mechanical compression |
BRPI0510034A (pt) * | 2004-05-21 | 2007-10-02 | Alza Corp | forma de dosagem para distribuição de múltiplas formas de fármacos |
WO2006007323A2 (en) * | 2004-06-28 | 2006-01-19 | Alza Corporation | Dosage forms for low solubility and/or low dissolution rate free acid pharmaceutical agents |
EP1771159A4 (en) * | 2004-07-22 | 2009-04-29 | Amorepacific Corp | SLOW RELEASE PREPARATIONS CONTAINING TOPIRAMATE AND PROCESS FOR PRODUCING THE SAME |
US20060045865A1 (en) * | 2004-08-27 | 2006-03-02 | Spherics, Inc. | Controlled regional oral delivery |
US20070281007A1 (en) * | 2004-08-27 | 2007-12-06 | Jacob Jules S | Mucoadhesive Oral Formulations of High Permeability, High Solubility Drugs |
US8541026B2 (en) | 2004-09-24 | 2013-09-24 | Abbvie Inc. | Sustained release formulations of opioid and nonopioid analgesics |
CA2596029A1 (en) * | 2005-01-27 | 2006-08-03 | David E. Edgren | Oral osmotic dosage form having a high flux membrane |
IS7748A (is) * | 2005-03-17 | 2006-09-18 | Actavis Group | Samsetning fyrir töflur sem innihalda topiramate |
US20080318910A1 (en) * | 2005-10-04 | 2008-12-25 | Mistral Pharma, Inc. | Controlled-Release Oral Dosage Form |
WO2007044234A1 (en) * | 2005-10-07 | 2007-04-19 | Alza Corporation | Osmotic dosage form with controlled release and fast release aspects |
WO2008027557A2 (en) * | 2006-08-31 | 2008-03-06 | Spherics, Inc. | Topiramate compositions and methods of enhancing its bioavailability |
GB2443738A (en) * | 2006-11-09 | 2008-05-14 | Proprius Pharmaceuticals Inc | A sustained release methotrexate composition and methods of use thereof |
DE07870164T1 (de) | 2006-11-17 | 2009-02-19 | Supernus Pharmaceuticals, Inc. | Verzögert freigesetzte formulierungen aus topiramat |
EP2061431B1 (en) * | 2006-12-04 | 2013-04-24 | Supernus Pharmaceuticals, Inc. | Enhanced immediate release formulations of topiramate |
AU2008258596B2 (en) | 2007-06-04 | 2013-02-14 | Egalet Ltd | Controlled release pharmaceutical compositions for prolonged effect |
EP2393484A1 (en) | 2009-02-06 | 2011-12-14 | Egalet Ltd. | Immediate release composition resistant to abuse by intake of alcohol |
WO2010100657A2 (en) | 2009-03-04 | 2010-09-10 | Fdc Limited | A novel oral controlled release dosage forms for water soluble drugs |
EP2445487A2 (en) | 2009-06-24 | 2012-05-02 | Egalet Ltd. | Controlled release formulations |
US8652527B1 (en) | 2013-03-13 | 2014-02-18 | Upsher-Smith Laboratories, Inc | Extended-release topiramate capsules |
US9101545B2 (en) | 2013-03-15 | 2015-08-11 | Upsher-Smith Laboratories, Inc. | Extended-release topiramate capsules |
US10195151B2 (en) | 2016-09-06 | 2019-02-05 | Jazz Pharmaceuticals International Iii Limited | Formulations of (R)-2-amino-3-phenylpropyl carbamate |
CN111201014A (zh) | 2017-06-02 | 2020-05-26 | 爱尔兰贾兹制药有限公司 | 治疗过度嗜睡的方法和组合物 |
US10940133B1 (en) | 2020-03-19 | 2021-03-09 | Jazz Pharmaceuticals Ireland Limited | Methods of providing solriamfetol therapy to subjects with impaired renal function |
CN115318353B (zh) * | 2022-08-31 | 2023-09-22 | 江苏举世检测有限公司 | 一种应用于管、瓶类卷口容器的恒温水浴锅及使用方法 |
Family Cites Families (80)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US488168A (en) * | 1892-12-13 | Furnace for burning garbage | ||
US2799241A (en) * | 1949-01-21 | 1957-07-16 | Wisconsin Alumni Res Found | Means for applying coatings to tablets or the like |
US3173876A (en) * | 1960-05-27 | 1965-03-16 | John C Zobrist | Cleaning methods and compositions |
NL271831A (ja) * | 1960-11-29 | |||
US3276586A (en) * | 1963-08-30 | 1966-10-04 | Rosaen Filter Co | Indicating means for fluid filters |
US3546142A (en) * | 1967-01-19 | 1970-12-08 | Amicon Corp | Polyelectrolyte structures |
US3541006A (en) * | 1968-07-03 | 1970-11-17 | Amicon Corp | Ultrafiltration process |
US3541005A (en) * | 1969-02-05 | 1970-11-17 | Amicon Corp | Continuous ultrafiltration of macromolecular solutions |
US3995631A (en) * | 1971-01-13 | 1976-12-07 | Alza Corporation | Osmotic dispenser with means for dispensing active agent responsive to osmotic gradient |
US3865108A (en) * | 1971-05-17 | 1975-02-11 | Ortho Pharma Corp | Expandable drug delivery device |
US3845770A (en) * | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
US3916899A (en) * | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
US4002173A (en) * | 1974-07-23 | 1977-01-11 | International Paper Company | Diester crosslinked polyglucan hydrogels and reticulated sponges thereof |
GB1478759A (en) * | 1974-11-18 | 1977-07-06 | Alza Corp | Process for forming outlet passageways in pills using a laser |
US4077407A (en) * | 1975-11-24 | 1978-03-07 | Alza Corporation | Osmotic devices having composite walls |
US4008719A (en) * | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
US4111202A (en) * | 1976-11-22 | 1978-09-05 | Alza Corporation | Osmotic system for the controlled and delivery of agent over time |
US4111201A (en) * | 1976-11-22 | 1978-09-05 | Alza Corporation | Osmotic system for delivering selected beneficial agents having varying degrees of solubility |
US4207893A (en) * | 1977-08-29 | 1980-06-17 | Alza Corporation | Device using hydrophilic polymer for delivering drug to biological environment |
US4327725A (en) * | 1980-11-25 | 1982-05-04 | Alza Corporation | Osmotic device with hydrogel driving member |
US4519801A (en) * | 1982-07-12 | 1985-05-28 | Alza Corporation | Osmotic device with wall comprising cellulose ether and permeability enhancer |
US4578075A (en) * | 1982-12-20 | 1986-03-25 | Alza Corporation | Delivery system housing a plurality of delivery devices |
US4681583A (en) * | 1982-12-20 | 1987-07-21 | Alza Corporation | System for dispersing drug in biological environment |
US4513006A (en) * | 1983-09-26 | 1985-04-23 | Mcneil Lab., Inc. | Anticonvulsant sulfamate derivatives |
US5082655A (en) * | 1984-07-23 | 1992-01-21 | Zetachron, Inc. | Pharmaceutical composition for drugs subject to supercooling |
US4892778A (en) * | 1987-05-27 | 1990-01-09 | Alza Corporation | Juxtaposed laminated arrangement |
US4940465A (en) * | 1987-05-27 | 1990-07-10 | Felix Theeuwes | Dispenser comprising displaceable matrix with solid state properties |
US4957494A (en) * | 1987-06-25 | 1990-09-18 | Alza Corporation | Multi-layer delivery system |
US5023088A (en) * | 1987-06-25 | 1991-06-11 | Alza Corporation | Multi-unit delivery system |
US5340590A (en) * | 1987-06-25 | 1994-08-23 | Alza Corporation | Delivery system with bilayer osmotic engine |
US5938654A (en) * | 1987-06-25 | 1999-08-17 | Alza Corporation | Osmotic device for delayed delivery of agent |
US5110597A (en) * | 1987-06-25 | 1992-05-05 | Alza Corporation | Multi-unit delivery system |
US5391381A (en) * | 1987-06-25 | 1995-02-21 | Alza Corporation | Dispenser capable of delivering plurality of drug units |
US4824675A (en) * | 1987-07-13 | 1989-04-25 | Alza Corporation | Dispenser with movable matrix comprising a plurality of tiny pills |
US4915949A (en) * | 1987-07-13 | 1990-04-10 | Alza Corporation | Dispenser with movable matrix comprising a plurality of tiny pills |
US4853229A (en) * | 1987-10-26 | 1989-08-01 | Alza Corporation | Method for adminstering tiny pills |
US4961932A (en) * | 1987-10-26 | 1990-10-09 | Alza Corporation | Plurality of tiny pills in liquid dosage form |
US5019397A (en) * | 1988-04-21 | 1991-05-28 | Alza Corporation | Aqueous emulsion for pharmaceutical dosage form |
US4931285A (en) * | 1988-04-28 | 1990-06-05 | Alza Corporation | Aqueous based pharmaceutical coating composition for dosage forms |
US5024842A (en) * | 1988-04-28 | 1991-06-18 | Alza Corporation | Annealed coats |
US5006346A (en) * | 1988-04-28 | 1991-04-09 | Alza Corporation | Delivery system |
US5160743A (en) * | 1988-04-28 | 1992-11-03 | Alza Corporation | Annealed composition for pharmaceutically acceptable drug |
US5324280A (en) * | 1990-04-02 | 1994-06-28 | Alza Corporation | Osmotic dosage system for delivering a formulation comprising liquid carrier and drug |
US5156850A (en) * | 1990-08-31 | 1992-10-20 | Alza Corporation | Dosage form for time-varying patterns of drug delivery |
US5190765A (en) * | 1991-06-27 | 1993-03-02 | Alza Corporation | Therapy delayed |
US5252338A (en) * | 1991-06-27 | 1993-10-12 | Alza Corporation | Therapy delayed |
AU651244B2 (en) * | 1991-09-19 | 1994-07-14 | Mcneilab, Inc. | Process for the preparation of chlorosulfate and sulfamate derivatives of 2,3:4,5-bis-0-(1-methylethylidene)-beta-D- fructopyranose and (1-methylcyclohexyl)methanol |
US5262171A (en) * | 1991-11-25 | 1993-11-16 | Isp Investments Inc. | Pharmaceutical tablet with PVP having enhanced drug dissolution rate |
US5413672A (en) * | 1992-07-22 | 1995-05-09 | Ngk Insulators, Ltd. | Method of etching sendust and method of pattern-etching sendust and chromium films |
US5817321A (en) * | 1992-10-08 | 1998-10-06 | Supratek Pharma, Inc. | Biological agent compositions |
ZA953078B (en) * | 1994-04-28 | 1996-01-05 | Alza Corp | Effective therapy for epilepsies |
US5633011A (en) * | 1994-08-04 | 1997-05-27 | Alza Corporation | Progesterone replacement therapy |
US5614578A (en) * | 1994-10-28 | 1997-03-25 | Alza Corporation | Injection-molded dosage form |
US5753693A (en) * | 1996-06-28 | 1998-05-19 | Ortho Pharmaceutical Corporation | Anticonvulsant derivatives useful in treating manic-depressive bipolar disorder |
US6919373B1 (en) * | 1996-11-12 | 2005-07-19 | Alza Corporation | Methods and devices for providing prolonged drug therapy |
ATE216220T1 (de) * | 1997-12-05 | 2002-05-15 | Alza Corp | Osmotische darreichungsform mit zwei mantelschichten |
UA65607C2 (uk) * | 1998-03-04 | 2004-04-15 | Орто-Макнейл Фармацевтикал, Інк. | Фармацевтична композиція (варіанти) та спосіб її приготування |
US6174547B1 (en) * | 1999-07-14 | 2001-01-16 | Alza Corporation | Dosage form comprising liquid formulation |
PT1126853E (pt) * | 1998-11-02 | 2006-07-31 | Alza Corp | Distribuicao controlada de anti-depressivos |
NZ511465A (en) * | 1998-11-02 | 2003-10-31 | Alza Corp | Controlled delivery of active agents |
SI20150A (sl) * | 1999-02-19 | 2000-08-31 | Lek, Tovarna Farmacevtskih In | Direktno stisljivi matriks za nadzorovano sproščanje celodnevne doze klaritromicina |
US6294192B1 (en) * | 1999-02-26 | 2001-09-25 | Lipocine, Inc. | Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents |
US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
MXPA01012187A (es) * | 1999-05-28 | 2002-06-21 | Jeffrey Berlant | Compuestos y metodos para el tratamiento del trastorno por estres postraumatico. |
US6562375B1 (en) * | 1999-08-04 | 2003-05-13 | Yamanouchi Pharmaceuticals, Co., Ltd. | Stable pharmaceutical composition for oral use |
US6491949B2 (en) * | 2000-01-14 | 2002-12-10 | Osmotica Corp. | Osmotic device within an osmotic device |
US7678387B2 (en) * | 2000-06-06 | 2010-03-16 | Capricorn Pharma, Inc. | Drug delivery systems |
US20020044962A1 (en) * | 2000-06-06 | 2002-04-18 | Cherukuri S. Rao | Encapsulation products for controlled or extended release |
US6488962B1 (en) * | 2000-06-20 | 2002-12-03 | Depomed, Inc. | Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms |
US6946243B2 (en) * | 2000-07-20 | 2005-09-20 | Solvay Pharmaceuticals Gmbh | Method of identifying compounds suitable for treatment and/or prophylaxis of obesity |
AU2002219935A1 (en) * | 2000-11-28 | 2002-06-11 | Focal, Inc. | Polyalkylene glycol viscosity-enhancing polymeric formulations |
US6610326B2 (en) * | 2001-02-16 | 2003-08-26 | Andrx Corporation | Divalproex sodium tablets |
ES2246009T3 (es) * | 2001-04-10 | 2006-02-01 | Soplar Sa | Dispositivo para la fabricacion de cuerpos huecos de plastico en un procedimiento de moldeado por extrusion y soplado. |
US20030021841A1 (en) * | 2001-07-02 | 2003-01-30 | Matharu Amol Singh | Pharmaceutical composition |
US20030091630A1 (en) * | 2001-10-25 | 2003-05-15 | Jenny Louie-Helm | Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data |
US20030185882A1 (en) * | 2001-11-06 | 2003-10-02 | Vergez Juan A. | Pharmaceutical compositions containing oxybutynin |
EP1469832B2 (en) * | 2002-02-01 | 2016-10-26 | Bend Research, Inc. | Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials |
US6559293B1 (en) * | 2002-02-15 | 2003-05-06 | Transform Pharmaceuticals, Inc. | Topiramate sodium trihydrate |
US7148211B2 (en) * | 2002-09-18 | 2006-12-12 | Genzyme Corporation | Formulation for lipophilic agents |
US7611728B2 (en) * | 2003-09-05 | 2009-11-03 | Supernus Pharmaceuticals, Inc. | Osmotic delivery of therapeutic compounds by solubility enhancement |
-
2003
- 2003-07-28 AU AU2003256848A patent/AU2003256848A1/en not_active Abandoned
- 2003-07-28 EP EP03771915A patent/EP1534238A1/en not_active Withdrawn
- 2003-07-28 WO PCT/US2003/023438 patent/WO2004010970A1/en active Application Filing
- 2003-07-28 MX MXPA05001184A patent/MXPA05001184A/es unknown
- 2003-07-28 NZ NZ537543A patent/NZ537543A/en unknown
- 2003-07-28 US US10/628,970 patent/US20040115262A1/en not_active Abandoned
- 2003-07-28 JP JP2005505623A patent/JP2005536568A/ja not_active Withdrawn
- 2003-07-28 CA CA002494233A patent/CA2494233A1/en not_active Abandoned
- 2003-07-29 AR AR20030102718A patent/AR040722A1/es unknown
- 2003-07-29 TW TW092120701A patent/TW200410728A/zh unknown
- 2003-07-30 PE PE2003000750A patent/PE20040131A1/es not_active Application Discontinuation
- 2003-07-31 UY UY27908A patent/UY27908A1/es unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2005536568A5 (ja) | ||
RU2380092C2 (ru) | Быстро растворяющаяся пленка для доставки активного агента | |
AU739698B2 (en) | Water soluble film for oral administration with instant wettability | |
FI110160B (fi) | Molekyylipainoltaan erilaisia polymeerejä ja lääkeainetta sisältävän annosmuodon valmistusmenetelmä | |
CA2446712C (en) | System for osmotic delivery of pharmaceutically active agents | |
KR870009717A (ko) | 신규 경구용 약제 | |
JP2001520985A5 (ja) | ||
JP2006514058A (ja) | 薬物の経口投与用の急速溶解フィルム | |
ATE267581T1 (de) | Orale arzneiformen mit schneller auflösbarkeit im mund und verfahren zu ihrer herstellung | |
JPH04501425A (ja) | ロラタジン、イブプロフェンおよびプソイドエフェドリンを含む薬剤組成物 | |
WO2005065069A3 (en) | Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease | |
MY121105A (en) | Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent | |
EP1275381A4 (en) | SOLID COATED PREPARATIONS WITH TEMPERATURE RELEASE FOR ORAL ADMINISTRATION | |
ATE389389T1 (de) | Mehrfach beschichete pharmazeutische dosierungsform | |
CA2143413A1 (en) | Local Drug Delivery Film, for Periodontal Treatment | |
ATE375789T1 (de) | Orales abgabesystem mit einem antibakteriellen und einem entzündungshemmenden mittel | |
JP2002525266A5 (ja) | ||
US20030064101A1 (en) | Floating osmotic device for controlled release drug delivery | |
PT88405B (pt) | Dispositivo e forma de dosagem para a libertacao de diltiazem | |
ATE253354T1 (de) | Kapseln mit loratadin und pseudoephedrin enthaltenden zusammensetzungen | |
JP3170855B2 (ja) | イブプロフェン含有解熱鎮痛剤 | |
JP2003511403A5 (ja) | ||
JP2001511450A5 (ja) | ||
WO2017090902A1 (ko) | 구강 지혈 및 상처 보호 필름 | |
JP2004529893A5 (ja) |